OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection
Zhen Xu, Yunting Zou, Xi Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Zhen Xu, Yunting Zou, Xi Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Showing 6 citing articles:
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1798-1798
Open Access | Times Cited: 10
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1798-1798
Open Access | Times Cited: 10
Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease
Takashi Miura, Tika R. Malla, Lennart Brewitz, et al.
Bulletin of the Chemical Society of Japan (2024) Vol. 97, Iss. 5
Open Access | Times Cited: 6
Takashi Miura, Tika R. Malla, Lennart Brewitz, et al.
Bulletin of the Chemical Society of Japan (2024) Vol. 97, Iss. 5
Open Access | Times Cited: 6
Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies
Chunfang Hu, Ting Guo, Yunting Zou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Chunfang Hu, Ting Guo, Yunting Zou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection
Shuang Mei, Yunting Zou, Su Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115908-115908
Closed Access | Times Cited: 5
Shuang Mei, Yunting Zou, Su Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115908-115908
Closed Access | Times Cited: 5
Bing Ye, Letian Song, Meehyein Kim, et al.
(2024), pp. 405-421
Closed Access
Antiviral peptides inhibiting the main protease of SARS‐CoV‐2 investigated by computational screening and in vitro protease assay
James T. Stewart, Jakaria Shawon, Muhammad Ali, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 4
Open Access
James T. Stewart, Jakaria Shawon, Muhammad Ali, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 4
Open Access
